View in EDS

Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration.

Saved in:
Bibliographic Details
Title: Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration.
Authors: Abreu de Góes, Vitor1 (AUTHOR), Lee, Matthew1 (AUTHOR), Zugman, Miguel1 (AUTHOR), Moradi, Ali1 (AUTHOR), Jaime-Casas, Salvador1 (AUTHOR), Shah, Koral1 (AUTHOR), Jun Li, Yu1 (AUTHOR), V. Castro, Daniela1 (AUTHOR), Li, Xiaochen1 (AUTHOR), Mercier, Benjamin1 (AUTHOR), Hsu, Joann1 (AUTHOR), Chehrazi-Raffle, Alexander1 (AUTHOR), Doctor, Vicki2,3,4 (AUTHOR), Moran, Amber2,3,4 (AUTHOR), Markman, Maurie2,3,4 (AUTHOR), Shreenivas, Aditya1 (AUTHOR) ashreenivas@coh.org, Pal, Sumanta Kumar1 (AUTHOR)
Source: JCO Precision Oncology. 5/18/2026, Vol. 10, p1-7. 7p.
Database: Academic Search Ultimate
Description
ISSN:24734284
DOI:10.1200/PO-26-00121